Recent Updates
Recently added Catalysts
VALN Positive Sentiment

Valneva Sweden at the opening ceremony for International Vaccine Institute’s new European office in Stockholm

Thursday, May 30, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Valneva Sweden participated in the opening ceremony of the International Vaccine Institute's new European office in Stockholm on May 3, 2024. The event emphasized the importance of public-private partnerships in vaccine research and development. Key figures from IVI and academia discussed strategies for enhancing global health through innovative vaccine solutions.
Price reaction · baseline $8.89 (2024-05-29 close) · hit pre-market · 3 other VALN headline(s) in the window, move may be shared
day 0 close
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Valneva's participation highlights its commitment to global health.
  • The event promotes public-private partnerships in vaccine development.
  • The opening of IVI's European office is a significant milestone.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+97%
120-day peak, hindsight
Typical move
7%
average across 2 past catalysts
Lead asset
VLA2001
Phase 3 · SARS-CoV-2 Virus Infection

Full Press Release Details

Back to Stories
Sweden

Valneva Sweden at the opening ceremony for International Vaccine Institute’s new European office in Stockholm

Author: Valneva Sweden
• Share This Story
Share This Story
Valneva Sweden was honored to attend the opening ceremony for International Vaccine Institute (IVI) ’s new European office in Stockholm on May 3, 2024. This ceremony was special, as it marked a significant milestone for our partners in their commitment to fostering global health through innovative vaccine research and development.
The event also included several presentations and discussions around the central theme of using public-private partnerships for the discovery, development and delivery of vaccines for global health, including remarks from IVI Director General Jerome Kim, T. Anh WARTEL, MD (Deputy Director General International Vaccine Institute/Director of the Europe Regional Office), Jan Holmgren (Professor, University of Gothenburg), Sushant Sahastrabuddhe, MD, MPH,MBA (Associate Director General, International Vaccine Institute) and Kwasi Amfo (CEPI (Coalition for Epidemic Preparedness Innovations).

More Stories

See All Stories

Making Sustainability Durable: Why Governance Matters in Healthcare

Why Prevention Must be at the Center of the Lyme Disease Response

Leadership

Opportunities and Challenges of Being a Dual-Listed Company

Frequently Asked Questions

What event did Valneva Sweden attend?

Valneva Sweden attended the opening ceremony for IVI's new European office.

When was the opening ceremony held?

The opening ceremony took place on May 3, 2024.

What was the main theme of the event?

The event focused on public-private partnerships for vaccine development.

Who were some speakers at the ceremony?

Speakers included IVI Director General Jerome Kim and other health leaders.

ShareAdd on Google
Tags: VALN Viatris Investor Conferences Healthcare Valneva International Vaccine Institute vaccine development global health public-private partnerships
Last updated: May 30, 2024

Biotech snapshot

Lead asset
VLA2001Phase 3
SARS-CoV-2 Virus Infection →

Catalyst track record

+97%
best trade around VALN's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for VALN.

See every catalyst's timing & PoA →